logo
Largest Shark To Ever Swim In Our Oceans Was Not A Picky Eater

Largest Shark To Ever Swim In Our Oceans Was Not A Picky Eater

Forbes26-05-2025

Fossil O. megalodon tooth compared to a recent-day great white shark tooth.
Otodus megalodon, the largest shark to ever swim in our planet's oceans, still inhabited the sea up to around 3.6 million years ago.
Despite its fame in pop-culture, surprisingly little is known about the anatomy and behavior of this species. Sharks have only a cartilaginous skeleton that quickly decays after death, only their hard teeth survive the long and arduous fossilization process.
Based on the fragmentary remains, length estimates for a full-grown O. megalodon range from 50 to 100 feet (15-30 meters). Special evolutionary adaptions including warm-bloodedness (an organism's ability to maintain a relatively constant internal temperature) and giving birth to fully-developed newborns likely led to this gigantism.
The living animal required around 100,000 kilocalories per day. Scientists widely assumed that O. megalodon's main calorie intake was in the form of whales, large preys providing also a high-caloric input thanks to their fat reserves.
However O. megalodon was not a picky eater, says Dr. Jeremy McCormack from the Department of Geosciences at Goethe University Frankfurt.
McCormack and colleagues extracted zinc from the fossil teeth, an element that occurs in isotopes of different weights. Zinc is ingested with food, but the specific isotopes preserved in muscles, organs and skeletal tissues depend on the animal's place in the food chain. The tissue of large fish that eat smaller fish absorbs significantly less zinc-66, and predatory animal which, in turn, hunt them for food absorb even less.
"Since we don't know how the ratio of the two zinc isotopes at the bottom of the food pyramid was at that time, we compared the teeth of various prehistoric and extant shark species with each other and with other animal species. This enabled us to gain an impression of predator-prey relationships," explains McCormack.
The fossils they used for their study mostly came from marine deposits in Sigmaringen and Passau (Germany). Analyzing the zinc isotopes in the fossil remains of different species, they reconstructed the food chain as it appeared 18 million years ago.
"Sea bream, which fed on mussels, snails and crustaceans, formed the lowest level of the food chain we studied. Smaller shark species such as requiem sharks and ancestors of today's cetaceans, dolphins and whales, were next. Larger sharks such as sand tiger sharks were further up the food pyramid, and at the top were giant sharks like Araloselachus cuspidatus and the Otodus sharks, which include megalodon," explains McCormack.
The zinc signal in fossil O. megalodon teeth is more variable than expected. 'Our study tends rather to draw a picture of megalodon as an ecologically versatile generalist; … by all means flexible enough to feed on marine mammals and large fish, from the top of the food pyramid as well as lower levels — depending on availability.'
"It gives us important insights into how the marine communities have changed over geologic time, but more importantly the fact that even 'supercarnivores' are not immune to extinction," adds Kenshu Shimada, a paleobiologist at DePaul University in Chicago, U.S., and a coauthor of the new study.
The study,"Miocene marine vertebrate trophic ecology reveals megatooth sharks as opportunistic supercarnivores," was published in the journal Earth and Planetary Science Letters.
Additional material and interviews provided by Sadie Harley and Robert Egan, Goethe University Frankfurt am Main.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CMR in MINOCA Linked to Improved Diagnosis and Management
CMR in MINOCA Linked to Improved Diagnosis and Management

Medscape

timean hour ago

  • Medscape

CMR in MINOCA Linked to Improved Diagnosis and Management

TOPLINE: In a prospective study of over 300 patients with myocardial infarction with nonobstructive coronary arteries (MINOCA), cardiovascular magnetic resonance (CMR) was associated with meaningful changes in clinical diagnosis and/or management in 63% of patients and a similar increase in diagnostic certainty. METHODOLOGY: Previous CMR studies in MINOCA have focused on radiologic yield — a limited metric that does not reflect real‐world clinical utility. Prospective data on patient care are lacking. This prospective study conducted in Australia and the UK assessed the impact of CMR on diagnosis and management in 320 patients with MINOCA (mean age, 55.6 years; 52% men) recruited between January 2019 and July 2023. Patients were included if they had a hospital admission with acute features consistent with the Fourth Universal Definition of Myocardial Infarction, no obstructive coronary artery disease on angiography, and a clinician assessment indicating acute myocardial infarction as the most likely presentation. The treating cardiologists completed a questionnaire before and after CMR to record their working diagnosis, rate diagnostic certainty on a 1-10 scale (10 = most certain), and specify intended management, including medications and follow-up testing. The primary endpoint was a composite of change in clinical diagnosis or management after CMR. TAKEAWAY: CMR was associated with a change in diagnosis or management in 63% of patients (P < .001), with diagnosis revised in 38% and management changed in 50%. Diagnostic certainty increased significantly from a median score of 6-8 after CMR (P < .001), and diagnostic confidence numerically increased in 63% of patients. The absence of coronary atheroma, a pre-CMR diagnostic certainty score ≤ 5, and early CMR (performed within 14 days of hospital presentation) independently predicted a change in diagnosis or management, with 80% of patients with all three predictors vs 40% of those with none meeting the primary outcome. Of 172 patients initially prescribed dual antiplatelet therapy, 66 (38%) had it deprescribed following CMR, yielding a number needed to test of 3. IN PRACTICE: 'Integration of CMR into diagnostic imaging pathways may be reasonable to augment clinical diagnosis and management; however, further cost-effectiveness analyses are now warranted,' the study authors wrote. SOURCE: This study was led by Adil Rajwani, PhD, of the Royal Perth Hospital, Perth, Australia. It was published online on June 13, 2025, in Heart. LIMITATIONS: The study was limited by the impracticality of conducting a bias-free randomized trial of CMR vs no CMR. It was also limited by the assessment of CMR's impact only immediately after imaging, potentially missing later clinical insights. Medication protocols were not standardized, and the limited use of additional diagnostics such as optical coherence tomography may have influenced the findings. DISCLOSURES: This study was funded by a grant from the Royal Perth Hospital Medical Research Foundation in Australia. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Why nightmares could make you age faster and die sooner
Why nightmares could make you age faster and die sooner

Yahoo

time5 hours ago

  • Yahoo

Why nightmares could make you age faster and die sooner

Frequent nightmares are linked to premature ageing and increase the risk of an early death, according to a new study. Adults who report weekly nightmares are more than three times likely to die before the age of 70 compared to those who rarely or never experience them, researchers found. The study found nightmares to be a 'stronger predictor of premature death' than smoking, obesity, poor diet, and low physical activity. The scientists warned the findings should be treated as a 'public health concern', but said people can reduce nightmares by managing stress. The team, led by Dr Abidemi Otaiku of the UK Dementia Research Institute, and Imperial College London, analysed data from 2,429 children aged eight to 10 and 183,012 adults aged 26 to 86 over a period of 19 years. The research, presented at the European Academy of Neurology (EAN) Congress this month, found that nightmares disrupt both sleep quality and duration, which impairs the body's overnight cellular restoration and repair ability. The combined impacts of chronic stress and disrupted sleep are likely to contribute to the accelerated ageing of our cells and bodies. Dr Otaiku said, 'Our sleeping brains cannot distinguish dreams from reality. That's why nightmares often wake us up sweating, gasping for breath, and with our hearts pounding – because our fight-or-flight response has been triggered. This stress reaction can be even more intense than anything we experience while awake.' He said: 'Nightmares lead to prolonged elevations of cortisol, a stress hormone closely linked to faster cellular ageing. For those who frequently experience nightmares, this cumulative stress may significantly impact the ageing process.' He added: 'Given how common and modifiable nightmares are, they should be taken far more seriously as a public health concern.' Researchers found that children and adults who had frequent nightmares also exhibited faster ageing. This accounted for approximately 40 per cent of those who had a higher risk of early death. Dr Otaiku said this was the first study to show nightmares can predict faster biological ageing and earlier mortality, even after accounting for other health issues. Even monthly nightmares were linked to faster ageing and increased mortality compared to those who had no nightmares. and the links were consistent across all ages, sexes, ethnicities, and mental health statuses. 'The good news is that nightmares can be prevented and treated,' said Dr Otaiku. Simple measures, such as maintaining good sleep hygiene, managing stress, seeking treatment for anxiety or depression and not watching scary films can be effective in reducing nightmares, he said.

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

Associated Press

time6 hours ago

  • Associated Press

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are associated with significantly accelerated biological ageing and a more than threefold increase in the risk of premature death. This study is the first to show that nightmares independently predict faster biological ageing and earlier mortality – even after accounting for other health issues. Led by Dr Abidemi Otaiku of the UK Dementia Research Institute and Imperial College London, the study analysed data from 2,429 children aged 8 to 10 and 183,012 adults aged 26 to 86 across six long-term population cohorts. Nightmare frequency in adults was self-reported at the start of the study, with participants followed for up to 19 years. For children, nightmare frequency was reported by their parents at the beginning of the study. Results showed that adults reporting weekly nightmares were more than three times as likely to die prematurely (before age 70) compared to those who rarely or never experienced nightmares. Children and adults with more frequent nightmares also exhibited faster biological ageing, which accounted for approximately 40% of the heightened mortality risk. Notably, weekly nightmares were found to be a stronger predictor of premature death than other established risk factors such as smoking, obesity, poor diet, and low physical activity. 'Our sleeping brains cannot distinguish dreams from reality', Dr Otaiku explained. 'That's why nightmares often wake us up sweating, gasping for breath, and with our hearts pounding – because our fight-or-flight response has been triggered. This stress reaction can be even more intense than anything we experience while awake.' He continued, 'Nightmares lead to prolonged elevations of cortisol, a stress hormone closely linked to faster cellular ageing. For those who frequently experience nightmares, this cumulative stress may significantly impact the ageing process. Additionally, nightmares disrupt both sleep quality and duration, impairing the body's essential overnight cellular restoration and repair. The combined effects of chronic stress and disrupted sleep likely contribute to the accelerated ageing of our cells and bodies.' The association between frequent nightmares and accelerated ageing remained consistent across all ages, sexes, ethnicities, and mental health statuses, indicating a universal effect. Even monthly nightmares were linked to faster ageing and increased mortality compared to rare or no nightmares, emphasising the importance of reducing nightmare frequency across the population. View original content: SOURCE European Academy of Neurology (EAN) Congress

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store